Journal
PHARMACEUTICS
Volume 14, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics14122693
Keywords
3D-printing; artificial intelligence; drug delivery; FDA regulations; microneedles
Categories
Funding
- National Science Foundation Grant (NSF CMMI Award)
- Center of Excellence in Product Design and Advanced Manufacturing at North Carolina A&T State University
- [1663128]
- [2100739]
- [2100850]
Ask authors/readers for more resources
This article reviews different 3D printing technologies with the potential to revolutionize the manufacturing of microneedles, highlighting their applications in various fields and the challenges they face. It also discusses FDA regulatory guidelines and the implementation of futuristic technologies for 3D printed microneedles, such as artificial intelligence algorithms and 4D printing capabilities.
Microneedles are micron-sized devices that are used for the transdermal administration of a wide range of active pharmaceutics substances with minimally invasive pain. In the past decade, various additive manufacturing technologies have been used for the fabrication of microneedles; however, they have limitations due to material compatibility and bioavailability and are time-consuming and expensive processes. Additive manufacturing (AM), which is popularly known as 3D-printing, is an innovative technology that builds three-dimensional solid objects (3D). This article provides a comprehensive review of the different 3D-printing technologies that have the potential to revolutionize the manufacturing of microneedles. The application of 3D-printed microneedles in various fields, such as drug delivery, vaccine delivery, cosmetics, therapy, tissue engineering, and diagnostics, are presented. This review also enumerates the challenges that are posed by the 3D-printing technologies, including the manufacturing cost, which limits its viability for large-scale production, the compatibility of the microneedle-based materials with human cells, and concerns around the efficient administration of large dosages of loaded microneedles. Furthermore, the optimization of microneedle design parameters and features for the best printing outcomes is of paramount interest. The Food and Drug Administration (FDA) regulatory guidelines relating to the safe use of microneedle devices are outlined. Finally, this review delineates the implementation of futuristic technologies, such as artificial intelligence algorithms, for 3D-printed microneedles and 4D-printing capabilities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available